WO2024160919 - AGENTS, COMPOSITIONS, AND METHODS FOR SUPPORTING BEHAVIOURAL DEVELOPMENT
National phase entry is expected:
Publication Number
WO/2024/160919
Publication Date
08.08.2024
International Application No.
PCT/EP2024/052415
International Filing Date
31.01.2024
Title **
[English]
AGENTS, COMPOSITIONS, AND METHODS FOR SUPPORTING BEHAVIOURAL DEVELOPMENT
[French]
AGENTS, COMPOSITIONS ET PROCÉDÉS DE SOUTIEN DE DÉVELOPPEMENT COMPORTEMENTAL
Applicants **
SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Avenue Nestlé 55
1800 VEVEY, CH
Inventors
RAJHANS, Purva
Ch. des Croix-Rouges 2
1007 LAUSANNE, CH
SCHNEIDER, Nora
Ch. Des Fontaines-Murée 31 A
1808 Les Monts-de-Corsier, CH
HAUSER, Jonas
39, Rue de l'Ale
1003 Lausanne, CH
ZHU, Hongtu
104 Tremont circle,
Chapel Hill,, North Carolina 27516, US
LI, Tengfei
1304 Drew Hill Lane
Chapel Hill, North Carolina 27514, US
CHO, Seoyoon
1351 Mason Farm Road
Apt 215B
Chapel Hill, North Carolina 27514, US
LIN, Weili
4502 Environ Way
Chapel Hill, North Carolina 27517, US
Priority Data
23154263.0
31.01.2023
EP
63/462,621
28.04.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1282 | |
| EPO | Filing, Examination | 5067 | |
| Japan | Filing | 614 | |
| South Korea | Filing | 609 | |
| USA | Filing, Examination | 2710 |
Total: 10282 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to one or more human milk oligosaccharides (HMOs) for use in supporting behavioural development in a subject, wherein the one or more HMOs comprise or consist of: (a) lacto-N-difucohexaose I (LNDFHI); and/or (b) 2'-fucosyllactose (2'FL), 3- fucosyllactose (3FL), lactodifucotetraose (LDFT), lacto-N-fucopentaose II (LNFPII), lacto-N- fucopentaose I (LNFP-I), lacto-N-fucopentaose III (LNFP-III), lacto-N-difucohexaose I (LND- I), monofucosyl-lacto-N-hexaose III (MFLNH-III), lacto-N-fucopentaose V (LNFP-V), lacto-N- neodifucohexaose (LNnDFH) and lacto-N-fucopentaose VI (LNFP-VI).[French]
La présente invention concerne un ou plusieurs oligosaccharides de lait humain (HMO) destinés à être utilisés dans le soutien du développement comportemental chez un sujet, l'HMO ou les HMO comprenant ou consistant en : (a) du lacto-N-difucohexaose I (LNDFHI) ; et/ou (b) du 2'-fucosyllactose (2'FL), du 3-fucosyllactose (3FL), du du lactodifucotétraose (LDFT), du lacto-N-fucopentaose II (LNFPII), du lacto-N-fucopentaose I (LNFP-I), du lacto-N-fucopentaose III (LNFP-III), du lacto-N-difucohexaose I (LND-I), du monofucosyl-lacto-N-hexaose III (MFLNH-III), du lacto-N-fucopentaose V (LNFP-V), du lacto-N-néodifucohexaose (LNnDFH) et du lacto-N-fucopentaose VI (LNFP-VI).